NCT05596279View on ClinicalTrials.gov

PANOVISION: Feasibility and Safety of Hybrid IVUS-OCT System

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

November 20, 2019

Primary Completion Date

August 12, 2020

Study Completion Date

July 30, 2021

Conditions
Coronary Artery DiseaseIntravascular Imaging Device
Interventions
DIAGNOSTIC_TEST

Intravascular ultrasound

Hybrid IVUS-OCT and control IVUS were performed after stenting

DIAGNOSTIC_TEST

Optical coherence tomography

Hybrid IVUS-OCT and control OCT were performed after stenting

Trial Locations (3)

150056

The Second Hospital of Jilin University, Changchun

150086

The Second Affiliated Hospital of Harbin Medical University, Harbin

430010

Wuhan Asia Heart Hospital, Wuhan

All Listed Sponsors
collaborator

Second Hospital of Jilin University

OTHER

collaborator

Wuhan Asia Heart Hospital

OTHER

collaborator

Panorama Hengsheng (Beijing) Science and Technology Co., Ltd.

UNKNOWN

lead

Harbin Medical University

OTHER

NCT05596279 - PANOVISION: Feasibility and Safety of Hybrid IVUS-OCT System | Biotech Hunter | Biotech Hunter